Deutsche Märkte geschlossen

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Verzögerter Preis. Währung in USD
Zur Watchlist hinzufügen
293,85-1,88 (-0,64%)
Börsenschluss: 04:00PM EDT
293,85 0,00 (0,00%)
Nachbörse: 04:51PM EDT

Bio-Rad Laboratories, Inc.

1000 Alfred Nobel Drive
Hercules, CA 94547
United States
510 724 7000
https://www.bio-rad.com

Sektor(en)Healthcare
BrancheMedical Devices
Vollzeitmitarbeiter8.000

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Norman D. SchwartzChairman, CEO & President1,25M19,51M1950
Dr. Andrew J. Last Ph.D.Executive VP & COO682,29kN/A1960
Mr. Roop K. LakkarajuExecutive VP & CFON/AN/A1971
Ms. Tania DeVilliersSenior Director, Corporate Controller & Interim Principal Accounting OfficerN/AN/A1974
Mr. Yong ChungVice President of Investor RelationsN/AN/AN/A
Ms. Colleen CoreyExecutive Vice President of Global Human ResourcesN/AN/A1962
Mr. Michael CrowleyExecutive Vice President of Global Commercial Operations974,94k1,85M1962
Lee BoydSenior Vice President of Global Commercial Operations - Asia PacificN/AN/AN/A
Mr. James J. BarryExecutive VP & President of Life Science GroupN/AN/AN/A
Kurt DeLangheSenior Vice President of Global Commercial Operations of Europe, Middle East & AfricaN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Corporate Governance

Bio-Rad Laboratories, Inc.s ISS Governance QualityScore, Stand 1. Mai 2024, lautet 10. Die grundlegenden Scores sind Audit: 9, Vorstand: 10, Shareholderrechte: 10, Kompensation: 4.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.